drugset / Trial / NCT01418300

Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial

NCT01418300

Phase 4 Completed 159 enrolled Jun-Won Chung
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to improve first line Helicobacter pylori eradication rate and to compare the sequential versus conventional triple therapy.

Timeline

Start
2010-08
Primary completion
2011-08
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 100 mg
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Metronidazole Small molecule 500 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Lansoprazole Other / unclassified 30 mg